UI
UBIVAC, INC.
SEC filingBiotechnology · Portland, OR
Amount raised$80Ksold at filing
Total offeringNot stated
Investors in the raise2count reported to the SEC
FiledAug 27, 2026first sale Aug 2, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Hong-Ming Hu, Ph.D.Executive Officer, Director
Bernard A. Fox, IIIExecutive Officer
Sung Poblete, R.N., Ph.D.Director
Bernard Fox, Ph.D.Executive Officer, Director
Executive officers, directors and promoters as listed on the Form D.